On the contrary, other signal pathways like AMPKɑ, MEK1/2, P44/42 MAPK and Wnt 3a were not found to be affected by TFLS, suggesting that the anti-PCa property of TFLS was majorly exerted by inhibiting AKT signaling pathway. The gene discussed is MAP2K1; the disease is posterior cortical atrophy.